3,521 Shares in The Clorox Company (NYSE:CLX) Acquired by Nicholson Wealth Management Group LLC

Nicholson Wealth Management Group LLC purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,521 shares of the company's stock, valued at approximately $574,000.

Several other large investors have also recently added to or reduced their stakes in the company. GoalVest Advisory LLC purchased a new position in shares of Clorox during the 1st quarter worth approximately $31,000. First Foundation Advisors purchased a new position in Clorox in the first quarter worth $31,000. Innealta Capital LLC acquired a new stake in Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its position in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after purchasing an additional 130 shares in the last quarter. Finally, Quarry LP boosted its position in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.51% of the company's stock.

Clorox Trading Down 1.4 %

Shares of NYSE:CLX traded down $2.29 during trading on Friday, reaching $156.69. The stock had a trading volume of 1,040,102 shares, compared to its average volume of 1,223,216. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The stock has a market cap of $19.46 billion, a P/E ratio of 81.19, a PEG ratio of 3.19 and a beta of 0.41. The business has a fifty day moving average price of $160.51 and a 200-day moving average price of $145.52. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.97 billion. As a group, analysts anticipate that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date is Wednesday, October 23rd. Clorox's dividend payout ratio is currently 252.85%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CLX shares. TD Cowen initiated coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a "sell" rating and a $122.00 price target for the company. Wells Fargo & Company reduced their price target on shares of Clorox from $135.00 to $130.00 and set an "underweight" rating for the company in a research report on Wednesday, July 10th. BNP Paribas upgraded Clorox to a "strong sell" rating in a report on Friday, September 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and raised their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Clorox from $144.00 to $151.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $150.14.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.